ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.90358
0.11%
Brent Oil
83.165
-0.37%
Bitcoin
63,132.86
-0.05%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
07/05/202415:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:KKellanova
07/05/202415:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RRyder System Inc
07/05/202415:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:WOWWideOpenWest Inc
07/05/202415:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OSPNOneSpan Inc
07/05/202415:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RXORXO Inc
07/05/202415:17Business WireRivian Releases First Quarter 2024 Financial ResultsNASDAQ:RIVNRivian Automotive Inc
07/05/202415:16Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:PTWOWPono Capital Two Inc
07/05/202415:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:GRSTEthema Health Corporation (PK)
07/05/202415:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CXTCrane NXT Co
07/05/202415:16Business WireCalifornia Desalination Association Welcomes Lacy Carothers, California American Water Director of Engineering, to Executive CommitteeNYSE:AWKAmerican Water Works
07/05/202415:16PR Newswire (US)SANDRIDGE ENERGY, INC. ANNOUNCES FINANCIAL AND OPERATING RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2024 AND DECLARES $0.11 PER SHARE CASH DIVIDENDNYSE:SDSandRidge Energy Inc
07/05/202415:16PR Newswire (US)Live Nation Entertainment To Participate In J.P. Morgan's 52nd Annual Global Technology, Media And Communications ConferenceNYSE:LYVLive Nation Entertainment Inc
07/05/202415:15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
07/05/202415:15GlobeNewswire Inc.Unusual Machines Formalizes CEO’s Contract for Two Years Along with Other Corporate UpdatesAMEX:UMACUnusual Machines Inc
07/05/202415:15GlobeNewswire Inc.Global Net Lease Reports First Quarter 2024 ResultsNYSE:GNLGlobal Net Lease Inc
07/05/202415:15GlobeNewswire Inc.Uniti Group Inc. to Participate at the Goldman Sachs 9th Annual Leveraged Finance and Credit ConferenceNASDAQ:UNITUniti Group Inc
07/05/202415:15Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:WPCWP Carey Inc
07/05/202415:15GlobeNewswire Inc.FTAI Infrastructure Inc. Reports First Quarter 2024 Results, Declares Dividend of $0.03 per Share of Common StockNASDAQ:FIPFTAI Infrastructure Inc
07/05/202415:15GlobeNewswire Inc.Occidental Announces First Quarter 2024 ResultsNYSE:OXYOccidental Petroleum Corporation
07/05/202415:15GlobeNewswire Inc.Globus Medical Reports First Quarter 2024 ResultsNYSE:GMEDGlobus Medical Inc
07/05/202415:15GlobeNewswire Inc.One Liberty Properties Reports First Quarter 2024 ResultsNYSE:OLPOne Liberty Properties Inc
07/05/202415:15GlobeNewswire Inc.CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)NASDAQ:CTMXCytomX Therapeutics Inc
07/05/202415:15Business WireEagle Point Credit Company Inc. Schedules Release of First Quarter 2024 Financial Results on Tuesday, May 21, 2024NYSE:ECCWEagle Point Credit Company Inc
07/05/202415:15GlobeNewswire Inc.Spectral AI Announces 2024 First Quarter Financial ResultsNASDAQ:MDAIWSpectral AI Inc
07/05/202415:15GlobeNewswire Inc.Certara Reports First Quarter 2024 Financial ResultsNASDAQ:CERTCertara Inc
07/05/202415:15GlobeNewswire Inc.Midland States Bancorp, Inc. Announces Common Stock and Preferred Stock DividendsNASDAQ:MSBIMidland States Bancorp Inc
07/05/202415:15GlobeNewswire Inc.Aterian Reports First Quarter 2024 ResultsNASDAQ:ATERAterian Inc
07/05/202415:15Business WireBio-Rad Reports First-Quarter 2024 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
07/05/202415:15GlobeNewswire Inc.COMPX REPORTS FIRST QUARTER 2024 RESULTSAMEX:CIXCompX International Inc
07/05/202415:15Business WirePROS Holdings, Inc. Reports First Quarter 2024 Financial ResultsNYSE:PROPros Holding Inc

Su Consulta Reciente

NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
NYSE
CVX
Chevron
FX
USDMXN
US Dollar vs MXN
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
FX
EURMXN
Euro vs MXN
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
PM
XAUUSD
Gold vs US Dollar
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados